Loxo Oncology (LOXO) Tops Q1 EPS by 10c

Loxo Oncology (NASDAQ: LOXO) reported Q1 EPS of ($0.59), $0.10 better than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Loxo Oncology (LOXO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Reading (RDI) Tops Q2 EPS by 4c